To organize the current status and understanding of liver resection in the treatment of hepatocellular car-cinoma, a questionnaire survey was conducted. The Kyushu Liver Surgery Study Group was sponsoring 15 in-stitutions including hepatologists and liver surgeons. Regarding the excision borderline, hepatologists felt limited by numbers and Vps, while surgeons felt limited by Vvs. In the case of BCLC-B, hepatologists had few choices for resection even if the treatment succeeded. Surgeons chose treatment for the conversion surgery attempt in the case of portal vein proximity, but hepatologists chose resection as a result after successful treat-ment. For the conversion attempt, most hepatologists hoped to use drug therapy or local treatment. It has be-come clear that hepatologists and surgeons must further change their mindset to perform hepatic resection and local or systemic therapy in the treatment of hepatocellular cancer.
!!!All Science Journal Classification (ASJC) codes